Enter either the number of shares you'd like to purchase OR the total investment you'd like to make.
View the EVO historical prices.
The 52 Week Low is $4.87 set on Tue, Mar 5, 2024.
The 52 Week High is $13.49 set on Thu, Jul 20, 2023. The current price, $5.02, is 0% below the 52 Week High.
The All-Time High is $26.53 set on Wed, Sep 15, 2021. The current price, $5.02, is 0% below the All Time High.
Below is the most recent stock split information. View EVO stock split history.
Stock Split Ex Date
Adjustment Factor
Below is the most recent dividend information. View complete EVO dividend history of 61 dividend payments to shareholders.
Annual Dividend Yield
Quarterly Dividend Rate
Declaration Date
Ex-Dividend Date
Record Date
Payment Date
Dividend Frequency
Dividend History
Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The EVT Execute segment, about 75% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis or integrated drug discovery collaborations. The EVT Innovate segment, about 25% of sales, develops proprietary drug discovery programs and assets, which can lead to partnerships with clients. As of 2022, the company has almost 5,000 employees and 17 production sites mainly in Europe and the United States.
Did you know you can earn $30 back on your first $30 of qualifying purchases with Rakuten?
Join now and start saving on every purchase from top retailers like Target, eBay, Zappos, Walmart, Kohl's & CVS. Whether you're shopping for fashion, electronics, home essentials, or health products, Rakuten makes it rewarding.
Sign up through this link and explore the endless possibilities to save and earn cash back!
Check out the Symbol Surfing blog to learn about investing.